Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ · Healthcare
Eloxx Pharmaceuticals, Inc. EBITDA 2010–2025
Eloxx Pharmaceuticals, Inc. annual/quarterly ebitda history and growth rate from 2010 to 2014. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Eloxx Pharmaceuticals, Inc. annual ebitda for 2014 was -8.8 M, a 101.94% increase from 2013.
- Eloxx Pharmaceuticals, Inc. annual ebitda for 2013 was -4.4 M, a 15.46% decrease from 2012.
- Eloxx Pharmaceuticals, Inc. annual ebitda for 2012 was -5.2 M, a 9.19% increase from 2010.
- Eloxx Pharmaceuticals, Inc. annual ebitda for 2010 was -4.7 M.
No data available.
Eloxx Pharmaceuticals, Inc. EBITDA — FAQ
Eloxx Pharmaceuticals, Inc. (ELOX) ebitda over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ELOX's ebitda history?
The chart and table above show Eloxx Pharmaceuticals, Inc.'s ebitda by year and by quarter, including the growth rate.